| payload |
{"created_at":"2026-04-03T19:59:44.196 {"created_at":"2026-04-03T19:59:44.196806+00:00","dedupe_key":"opportunity_case_memory:case_5bfceda8b8974ada:monitor:2026-04-03T19","evidence_event_ids":["evt_4c09a20e556b","evt_8b4bed4f75af"],"reason_trace":{"case_id":"case_5bfceda8b8974ada","decision":"monitor","entity_key":"equity:ZBIO","memory_only":true,"theme_key":"entity_development"},"severity":"low","signal_type":"opportunity_case_memory","source":"opportunity_finder","throttle_s":3600,"value":{"case_id":"case_5bfceda8b8974ada","confidence":0.32,"corroboration":{"agreement":{"count_score":0.5,"down_count":0,"magnitude_weighted_score":0.5,"majority_direction":"neutral","neutral_count":2,"score":0.5,"up_count":0},"base_score":0.4511,"claim_graph":{"case_signal_families":["filing"],"case_source_domains":["sec.gov"],"claims":[{"agreement_score":0.6,"claim_id":"claim_8de3a208f05ecad3","conflict":false,"direction":"neutral","evidence_count":2,"family_coverage":1,"quality_score":0.4803,"source_coverage":1,"source_trust":0.97,"statement":"ZBIO filed 4","strength":0.5492}],"coverage":{"claim_count":1,"conflicting_claims":0,"dominant_claim_id":"claim_8de3a208f05ecad3","multi_family_claims":0,"multi_source_claims":0},"score":0.3521},"contradiction":{"flags":[],"has_unresolved_conflict":false,"resolved_claims":[],"resolved_count":0,"score":0.0,"unresolved_claims":[],"unresolved_count":0},"contradiction_flags":["single_family_evidence","thin_independent_source_coverage"],"evidence_event_count":2,"high_precision_pass":false,"high_trust_source_coverage":1,"independent_source_coverage":1,"low_trust_source_coverage":0,"score":0.5375,"signal_family_coverage":1,"source_trust":{"avg_score":0.97,"domains":[{"count":2,"domain":"sec.gov","score":0.97,"source":"sec_edgar"}],"high_trust_domains":["sec.gov"],"independent_high_trust_sources":1,"low_trust_domains":[]},"source_trust_score":0.8055},"decision":"monitor","entity_key":"equity:ZBIO","evidence_event_count":2,"headline":"Zenas BioPharma, Inc. filed a Form 4 on April 2, 2026, reporting ownership changes in common stock.","personal_relevance_score":0.1,"theme_key":"entity_development","why_now":"Signal convergence: ZBIO filed 4 [neutral]"}}... |